Evoke Data Collection Study Germany
Completed
- Conditions
- Chronic Pain
- Registration Number
- NCT05272137
- Lead Sponsor
- Saluda Medical Pty Ltd
- Brief Summary
The objective of this multicentre study is to collect electrophysiological and device data from the Evoke Closed-Loop SCS system in the treatment of chronic pain of the trunk and/or limbs, in a real world setting under normal conditions of use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
- Patient approval for data collection and transfer of de-identified data to sponsor.
Exclusion Criteria
- No further exclusion criteria.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ECAP Measurement in Microvolts through 6 months post-implant Evoked Compound Action Potentials (ECAPs) as a measure of spinal cord activation
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neural pathways are modulated by closed-loop SCS in chronic trunk/limb pain management?
How does Saluda Medical's Evoke SCS system compare to standard-of-care SCS in chronic pain outcomes?
Which electrophysiological biomarkers predict response to closed-loop SCS in chronic pain patients?
What safety profiles and adverse event management strategies are associated with closed-loop SCS for chronic pain?
Are there combination therapies involving closed-loop SCS and pharmacological agents for chronic pain management?
Trial Locations
- Locations (1)
Universität Düsseldorf
🇩🇪Düsseldorf, North Rhine-Westphalia, Germany
Universität Düsseldorf🇩🇪Düsseldorf, North Rhine-Westphalia, Germany